Strategic Partnerships Adaptix has multiple recent distribution partnerships (Spartan Medical, Mid-South Medical Imaging, Discovery Medical Imaging) and North American market focus, signaling strong go-to-market momentum and potential co-selling opportunities with medical distributors and imaging providers.

Low-Dose Advantage The core capability is low-dose 3D X-ray imaging comparable in dose and cost to 2D, plus 3D digital tomosynthesis; this positions Adaptix to win in settings prioritizing dose reduction, patient safety, and cost efficiency across clinics, hospitals, and urgent care.

Imaging Expansion Product expansion into orthopedic and veterinary segments (Ortho350, mobile/vet radiography interest) creates cross-market sales potential with orthopedics, veterinary practices, and mobile imaging services seeking 3D capabilities at lower doses.

Evidence & Visibility Active participation in global events and demonstrations (JEC World, US installations, awards) enhances brand credibility; leverage case studies, demos, and ROI-focused content to unlock trials and accelerated pilots with care facilities and imaging centers.

Financial Readiness With growing revenue in the lower-to-mid multi-million range and a modest funding base, there is appetite for strategic investments, channel partnerships, and pilot programs to validate uptake in high-potential regions and capture share in 3D tomosynthesis adoption.